Drug Database
4-

4-factor prothrombin complex

✓ Approved

Intas Pharmaceuticals · F2 · 细胞治疗

什么是 4-factor prothrombin complex?

4-factor prothrombin complex 是一种细胞治疗,由Intas Pharmaceuticals研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intravenous (IV)。

药物档案

公司Intas Pharmaceuticals
药物类别细胞治疗
分子靶点F2, F7, F9, F10
给药途径Injectable (Others), Intravenous (IV)
状态Approved

作用机制

分子靶点

4-factor prothrombin complex 作用于 4 个分子靶点:

F2coagulation factor II, thrombin (THPH1, PT)
F7coagulation factor VII (SPCA)
F9coagulation factor IX (P19, F9 p22)
F10coagulation factor X (FXA, FX)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

4-factor prothrombin complex 针对 2 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Vascular disordersExtravasation blood✓ Approved
Vascular disordersHaemorrhage✓ Approved

相关研究文献

PubMedMagnetic resonance in medicine2026-11-19

Fast Voxelwise SNR Estimation for Iterative MRI Reconstructions.

Dalmaz Onat O, Abraham Daniel D, Toews Alexander R AR, Chaudhari Akshay S AS et al.

To develop a fast, general-purpose framework for voxelwise noise characterization in iterative MRI reconstructions, recovering the image-domain noise variance, the primary quantity from which SNR, g -factor, and related image-quality metrics are derived. The framework addresses both the intractability of closed-form formulas beyond Cartesian sampling and the long runtime of pseudo multiple replica (PMR). A stochastic noise estimator is proposed that operates in the image domain by Probing the Image-space noise COvariance matrix (PICO) with random probe images. Complex random-phase probes attain minimum kurtosis and reduce estimator variance in the tested reconstruction. PICO was validated against analytical benchmarks and PMR references using Cartesian knee data ( R = 2 ), physical brain phantom data ( R = 2 , 3 , 4 ), in vivo non-Cartesian brain data ( R = 2 ), and compressed-sensing knee reconstructions ( R = 2 ). In Cartesian reconstructions, PICO accurately reproduced analytical SENSE g -factor maps. In non-Cartesian reconstructions, it achieved 1 % g -factor NRMSE ≈ 11 . 9 × faster than PMR in a phantom and ≈ 2 . 81 × faster in vivo, with the efficiency advantage persisting at higher acceleration. For compressed sensing, the Jacobian-based estimator produced noise maps consistent with PMR and computed them 1 . 84 × faster at equal sample counts. Agreement worsened at large added-noise amplitudes and moderate TV strengths. PICO targets the exact covariance of fixed linear reconstructions and a first-order covariance for nonlinear reconstructions, providing a computationally efficient alternative to PMR. By reusing existing reconstruction primitives, it could help incorporate voxelwise noise maps into reconstruction workflows.

PMID 43053180
阅读全文 →
PubMedBMC neurology2026-11-19

Turkish validity and reliability of the Migraine Treatment Optimization Questionnaire-4 (MTOQ-4).

Aksoy Hilal H, Yıldız Nadide N, Fidanci Izzet I, Ayhan Başer Duygu D

The Migraine Treatment Optimization Questionnaire-4 (MTOQ-4) is a brief patient-reported instrument developed to evaluate the effectiveness of acute migraine treatment. This study aimed to assess the validity and reliability of the Turkish version of MTOQ-4. This methodological study was conducted between May and November 2025. After obtaining permission from the scale developer, the translation and cultural adaptation process included forward translation, expert panel review, back translation, and pilot testing. The study population consisted of adults diagnosed with migraine who attended a family medicine outpatient clinic. Sociodemographic data and the MTOQ-4 were administered face-to-face. Internal consistency was assessed using Cronbach's alpha. Construct validity was evaluated using exploratory factor analysis. Kaiser-Mayer-Olkin(KMO) and Bartlett's tests were applied to assess sample adequacy. Statistical analyses were performed using SPSS 23 and AMOS. The mean content validity index (S-CVI/Ave) at the scale level was calculated as 0.95. The Cronbach's Alpha coefficient, calculated to determine the internal consistency of the MTOQ-4 scale, was found to be 0.829. The KMO value was determined as 0.7887, and the Bartlett test was statistically significant (p < 0.001). The exploratory factor analysis showed that all factor loadings were above 0.60. The Turkish version of MTOQ-4 is expected to be a valid and reliable instrument for evaluating acute migraine treatment effectiveness in primary care.

PMID 43052836
阅读全文 →
PubMedMolecular genetics & genomic medicine2026-11-19

A Complex Chromosomal Rearrangement Involving Chromosomes X, 3, and 4 Characterized by Multi-Platform Genomic Technologies.

Luo Hualei H, Huang Juan J, Hassan Reem Nabil RN, Ye Yuhua Y et al.

Complex chromosomal rearrangements (CCRs) are rare structural alterations that can lead to growth failure and gonadal dysfunction. However, their phenotypic impact is often difficult to interpret, particularly in patients without congenital anomalies who present with unexplained short stature or gonadal dysgenesis. We evaluated a female pediatric patient presenting with persistent short stature, delayed bone age, and biochemical and imaging evidence of gonadal dysgenesis. The study employed an integrated approach: conventional karyotyping was first used to detect large-scale abnormalities, followed by optical genome mapping (OGM) for high-resolution breakpoint analysis. Genomic findings were correlated with clinical, radiographic, and imaging data. Karyotyping revealed a complex rearrangement involving chromosomes X, 3, and 4. OGM further resolved the architecture, identifying nine breakpoints resulting in three derivative chromosomes, and permitting classification as a type C (exceptional) CCR corresponding to Madan group IV. Key genes disrupted or repositioned included LRBA, CFAP44, EPHA3, CADM2, GALNTL6, and DCBLD2. The complex breakpoint pattern suggested a catastrophic event, such as chromothripsis, during early embryogenesis. Despite this genomic complexity, the patient lacked major malformations or intellectual disability, manifesting primarily with Turner syndrome-like features; biochemical testing established hypergonadotropic hypogonadism, whereas the short stature remained unexplained after growth hormone provocation. This case highlights the clinical utility of OGM in resolving cryptic CCRs elusive to conventional cytogenetics, while illustrating that extraction of maximal diagnostic information requires integration of structural, clinical and imaging data. It expands the phenotypic spectrum of CCRs, demonstrating that complex structural variants can be encountered in patients whose clinical presentation is otherwise confined to growth and gonadal manifestations, emphasizing the necessity of advanced genomic profiling for precise diagnosis and management.

PMID 43053632
阅读全文 →
PubMedPlant communications2026-11-19

Cooperative roles of three CrRLK1L family members in regulating plant growth and salt tolerance in Arabidopsis.

Wang Mingtao M, Liu Jianwei J, Liu Xin X, Li Zhihui Z et al.

FERONIA (FER) serves as a central signaling hub to coordinate cell wall integrity, developmental programs, and stress responses. FER contains a canonical intracellular kinase domain, but its essentiality has been debated, because the kinase-dead variant FERK565R retains the capacity to rescue fer mutant phenotypes. Here, we show that FERK565R, but not a variant lacking the entire cytoplasmic domain, fully rescues fer-4 defects in growth and salt tolerance. We further show that FER interacts with two related CrRLK1L members, THE1 and HERK1, and that these receptors reciprocally phosphorylate one another. Genetically, the the1-4 herk1 double mutant phenocopies fer-4 in both growth and salt sensitivity. Crucially, FERK565R loses its rescuing ability in the1-4 herk1-2 fer-4 triple mutant background, implying that THE1 and HERK1 are required for the function of this kinase-dead FER variant. Collectively, our findings unveil a model in which FER coordinates plant growth and salt stress responses by forming a complex with THE1/HERK1, wherein the loss of FER kinase activity can be functionally compensated by these homologs, providing new mechanistic insights into CrRLK1L signaling.

PMID 43053584
阅读全文 →
PubMedBMC psychiatry2026-11-19

Revision of the Hypomania Checklist-32 with a sample of Chinese psychiatric inpatients.

Li Wei W, Chen Lu L, Zhong Jie J

This study aimed to complete the revision of the Hypomania Checklist-32 (HCL-32) and systematically validate its psychometric properties in a sample of mainland Chinese psychiatric inpatients. A total of 519 consecutively recruited psychiatric inpatients were enrolled and completed the Chinese version of the HCL-32, the Generalized Anxiety Disorder-7 scale (GAD-7), the Patient Health Questionnaire-9 (PHQ-9), and the Symptom Checklist-90 (SCL-90). After quality control, 462 patients with complete and valid assessment data were included in the final statistical analysis. (1) The revised Chinese HCL-32 scale (HCL-32-R) comprised 25 items and yielded a stable three-factor structure, namely active/elevated, irritable/distractible, and impulsive/stimulating. Both exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) validated the robustness of this three-factor model. (2) All items demonstrated satisfactory factor loadings and aligned well with their corresponding factor dimensions. The Cronbach's α coefficient for the full HCL-32-R scale was 0.828, with coefficients of 0.944 for Factor 1, 0.742 for Factor 2, and 0.775 for Factor 3. The scale also exhibited favorable convergent validity, discriminant validity, and known-group discriminative capacity. (3) The total score of HCL-32-R, as well as the scores of Factor 2 and Factor 3, showed significant positive correlations with the total scores of the PHQ-9, GAD-7, and SCL-90 scales. (4) Statistically highly significant differences in HCL-32-R total scores were observed across distinct psychiatric diagnostic categories. The majority of psychometric indicators for the revised HCL-32-R meet acceptable psychometric standards. The scale demonstrates preliminary application potential for the assessment of hypomanic symptoms in Chinese psychiatric inpatient populations. However, due to the lack of validated optimal cut-off values, sensitivity and specificity data, and test-retest reliability evidence, HCL-32-R cannot be recommended for routine clinical screening use at this stage, and is only suitable for research-based symptom assessment pending further large-sample validation. Not applicable.

PMID 43052857
阅读全文 →
PubMedBMC bioinformatics2026-11-19

MAMTF: a method for predicting transcription factor binding sites combining state-space modeling and adaptive feature fusion.

Zhang Han H, Luo Junwei J, Shen Xiaohe X, Luo Fen F

Transcription factor binding sites (TFBSs) are short sequences on DNA that can be recognized and bound by specific transcription factors (TFs). Accurate identification of TFBSs is crucial for decoding gene regulatory mechanisms and understanding cellular functions. Traditional machine learning-based methods rely on manually designed features, making it difficult to fully uncover the complex patterns within DNA sequences. In recent years, deep learning methods have demonstrated significant advantages in TFBSs prediction. However, existing methods still have shortcomings in terms of local and global feature extraction as well as feature fusion. To address these issues, we propose a deep learning method, MAMTF, designed to integrate local and global DNA features to improve the performance of TFBSs prediction. This method uses a multiscale convolutional neural network to extract local sequence features, employs a bidirectional Mamba architecture to capture long-range dependencies, and designs a cross-gated fusion module to achieve deep interaction between different features. On 165 ChIP-seq datasets encompassing 29 transcription factor (TF) categories, MAMTF achieves a macro-averaged ACC (0.819), ROC-AUC (0.895) and PR-AUC (0.900) over the 29 TF categories, showing promising prediction ability. Experimental results show that MAMTF outperforms other six methods in predicting TFBSs, exhibiting optimal and stable performance on 29 TF categories, providing a new tool for accurate TFBSs prediction.

PMID 43052718
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多4-factor prothrombin complex